908 Devices (MASS) Gains from Investment Securities (2020 - 2025)
908 Devices (MASS) reported Gains from Investment Securities of -$22000.0 for Q4 2025, up 95.64% year-over-year from -$11244.9 in Q4 2024, and up 76.6% quarter-over-quarter from -$94000.0 in Q3 2025.
908 Devices (MASS) Gains from Investment Securities (2020 - 2025) Analysis & Trends
908 Devices (MASS) has 6 years of Gains from Investment Securities data on file, last reported at -$22000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$22000.0, up 95.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$211000.0 (up 55.11% YoY), and the FY2024 annual result was $2.6 million, up 7.41% from the prior year.
- Gains from Investment Securities grew to -$22000.0 in Q4 2025 per MASS's latest filing, from -$94000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $3.3 million in Q1 2025 and troughed at -$3.4 million in Q2 2025.
- A 5-year average of $185469.4 and a median of $40397.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2025: Gains from Investment Securities tumbled 13125.0% in 2021, then surged 7971.43% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$521000.0 in 2021, then surged by 142.99% to $224000.0 in 2022, then plunged by 133.48% to -$75000.0 in 2023, then tumbled by 573.33% to -$505000.0 in 2024, then surged by 95.64% to -$22000.0 in 2025.
- Business Quant data shows MASS's Gains from Investment Securities at -$22000.0 in Q4 2025, -$94000.0 in Q3 2025, and -$3.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | -505,000.00 |
| Dec 31, 2024 | -505,000.00 |
| Sep 30, 2024 | 53,794.00 |
| Sep 30, 2024 | 53,794.00 |
| Jun 30, 2024 | 53,794.00 |
| Jun 30, 2024 | 53,794.00 |
| Mar 31, 2024 | -42,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |